Session

08.09.2021     15:30–16:30

Title:
Poster Session 1
Type:
Poster Session

08.09.2021
15:30–16:30

Title:
Poster Session 1
Type:
Poster Session


15:30–15:33
P01 Clinical profile of chronic cluster headache (CCH) in a regional headache center in Japan
S. Kikui (Osaka/JP)
Talk time: 2 + 1 min


15:33–15:36
P02 Clinical characteristics and burden of a large series with cluster headache from Turkey  
P. Yalınay Dikmen (Istanbul/TR)
Talk time: 2 + 1 min


15:36–15:39
P03 Sphenopalatine Ganglion Volume in Cluster Headache: From Symptoms Laterality toward Treatment Prediction
J.-W. Wu (Taipei City, Taiwan/TW)
Talk time: 2 + 1 min


15:39–15:42
P04 Effect of Caffeine and Caffeine Cessation on Cerebrovascular Reactivity in Patients with Migraine 
Y.-E. Gil (Seoul/KR)
Talk time: 2 + 1 min


15:42–15:45
P05 Patient-physician interactive data sharing enhances patient engagement in digital migraine applications
T. Kelderman (Wilrijk/BE)
Talk time: 2 + 1 min


15:45–15:48
P06 Body Mass Index and Migraine Characteristics and Comorbidities in a Large Academic Headache Center
N. Murinova (Seattle, WA/US)
Talk time: 2 + 1 min


15:48–15:51
P07 Increased visual sensitivity in cluster headache, as quantified by the Leiden Visual Sensitivity Scale (L-VISS): a cross-sectional study
R. Brandt (Leiden/NL)
Talk time: 2 + 1 min


15:51–15:54
P08 Insights into real-world treatment of Cluster Headache through a large Italian database: prevalence, prescription patterns and costs
V. Favoni (Bologna/IT)
Talk time: 2 + 1 min


15:54–15:57
P09 Sleep Disorders in Pediatric Migraine: a questionnaire-based study
A. Voci (Rome/IT)
Talk time: 2 + 1 min


15:57–16:00
P010 Characteristics of pre-cluster symptoms in cluster headache
S. Cho (Uijeongbu/KR)
Talk time: 2 + 1 min


16:00–16:03
P011 Treatment pattern and response of cluster headache in Korea
M.-J. Lee (Seoul/KR)
Talk time: 2 + 1 min


16:03–16:06
P012 The Gut, the Brain and Migraine: When Pills Don"t Work
S. Aurora (Seattle, WA/US)
Talk time: 2 + 1 min


16:06–16:09
P013 Sleep assessment in patients with Cluster headache – self reported vs observed data
C. Ran (Stockholm/SE)
Talk time: 2 + 1 min


16:09–16:12
P014 Prevalence of pre-cluster symptoms in episodic cluster headache: Is it possible to predict an upcoming bout?
A. S. Pedersen (Glostrup/DK)
Talk time: 2 + 1 min


16:12–16:15
P015 Clock gene expression amongst a population of cluster headache patients
R. Oliveira (Lisbon/PT)
Talk time: 2 + 1 min


16:15–16:18
P016 Evaluating the real-world burden of migraine using Migraine Buddy
P. J. Goadsby (London/GB)
Talk time: 2 + 1 min


16:18–16:21
P017 Add on Treatment with Galacanezumab Improved Refractory Cluster Headache in 5 out of 6 Tested Cases
G. Karagiorgis (Athens/GR)
Talk time: 2 + 1 min


16:21–16:24
P018 Cluster Headache Impact Questionnaire (CHIQ) – A tool for assessing disability in cluster headache patients
K. Kamm (Munich/DE)
Talk time: 2 + 1 min


16:24–16:27
P019 Telencephalic Cortical Thickness in Chronic Cluster Headache
L. Giani (Milano/IT)
Talk time: 2 + 1 min


16:27–16:30
P020 Dopaminergic System Abnormalities in Chronic Cluster Headache Patients
L. Giani (Milano/IT)
Talk time: 2 + 1 min